MACROLIDE SENOLYTIC COMPOUNDS

Disclosed herein are macrolide compounds having senolytic activity. These compounds selectively target senescent cells, and may be used to reduce or eradicate senescent cells in a subject, and/or delay the onset of aging. These compounds also inhibit propagation of cancer stem cells, and may be used...

Full description

Saved in:
Bibliographic Details
Main Authors SOTGIA, Federica, LISANTI, Michael P, OZSVARI, Béla, KANGASMETSA, Jussi
Format Patent
LanguageEnglish
French
Published 07.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed herein are macrolide compounds having senolytic activity. These compounds selectively target senescent cells, and may be used to reduce or eradicate senescent cells in a subject, and/or delay the onset of aging. These compounds also inhibit propagation of cancer stem cells, and may be used to treat cancer, and in particular inhibit the propagation of cancer stem cells responsible for metastasis and tumor recurrence. Formulae (I) & (II): La présente divulgation concerne des composés macrolides ayant une activité sénolytique. Ces composés ciblent sélectivement les cellules sénescentes, et peuvent être utilisés pour réduire ou éradiquer des cellules sénescentes chez un sujet, et/ou retarder l'apparition du vieillissement. Ces composés inhibent également la propagation de cellules souches cancéreuses, et peuvent être utilisés pour traiter le cancer, et en particulier inhiber la propagation de cellules souches cancéreuses responsables de la métastase et de la récurrence tumorale. Formules (I) et (II) :
AbstractList Disclosed herein are macrolide compounds having senolytic activity. These compounds selectively target senescent cells, and may be used to reduce or eradicate senescent cells in a subject, and/or delay the onset of aging. These compounds also inhibit propagation of cancer stem cells, and may be used to treat cancer, and in particular inhibit the propagation of cancer stem cells responsible for metastasis and tumor recurrence. Formulae (I) & (II): La présente divulgation concerne des composés macrolides ayant une activité sénolytique. Ces composés ciblent sélectivement les cellules sénescentes, et peuvent être utilisés pour réduire ou éradiquer des cellules sénescentes chez un sujet, et/ou retarder l'apparition du vieillissement. Ces composés inhibent également la propagation de cellules souches cancéreuses, et peuvent être utilisés pour traiter le cancer, et en particulier inhiber la propagation de cellules souches cancéreuses responsables de la métastase et de la récurrence tumorale. Formules (I) et (II) :
Author LISANTI, Michael P
KANGASMETSA, Jussi
SOTGIA, Federica
OZSVARI, Béla
Author_xml – fullname: SOTGIA, Federica
– fullname: LISANTI, Michael P
– fullname: OZSVARI, Béla
– fullname: KANGASMETSA, Jussi
BookMark eNrjYmDJy89L5WSQ9XV0DvL38XRxVQh29fP3iQzxdFZw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkbGRsbGxgaGjobGxKkCAAaXI9o
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSÉS SÉNOLYTIQUES MACROLIDES
ExternalDocumentID WO2023233301A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2023233301A13
IEDL.DBID EVB
IngestDate Fri Jul 04 03:48:43 EDT 2025
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2023233301A13
Notes Application Number: WO2023IB55545
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231207&DB=EPODOC&CC=WO&NR=2023233301A1
ParticipantIDs epo_espacenet_WO2023233301A1
PublicationCentury 2000
PublicationDate 20231207
PublicationDateYYYYMMDD 2023-12-07
PublicationDate_xml – month: 12
  year: 2023
  text: 20231207
  day: 07
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies LUNELLA BIOTECH, INC
RelatedCompanies_xml – name: LUNELLA BIOTECH, INC
Score 3.419071
Snippet Disclosed herein are macrolide compounds having senolytic activity. These compounds selectively target senescent cells, and may be used to reduce or eradicate...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Title MACROLIDE SENOLYTIC COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231207&DB=EPODOC&locale=&CC=WO&NR=2023233301A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHJgWlb8V-ptvDkC1t2WRtytbpfBpploEgc7iK_77X0Ome9pbk4JIcXC6_3EcAHoSzaEvX4YZJJDdctJhGW1rckEu-NIX0bamy0uKEDKbu88yb1eBjmwuj6oT-qOKIqFEC9b1Q5_X6_xErULGVm8f8HYc-n6KsG-gVOsbLim36etDvhikLGNUpRdymJ2NFsx0E71YPsdKB7TmkDAAMX_plXsp616hEp3CYIr9VcQY1uWrAMd3-vdaAo7hyeWOz0r7NObTiHh2z0TAItUmYsNFbNqQaZXHKpkkwuYD7KMzowMB55n_bmr-y3UU5l1BHwC-vQONWO3cF7xBboBgl6RBRohBOhOtJwr1raO7jdLOffAsnZVeFZPhNqBdf37KFhrXI75Q8fgE9tHg6
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYPUBLN3hbHPsp4IAbaEdBtXWAoPpFSS2JikMiM_763ZihPvDW95Npe8uv1195dAe6k8-Yr1xGmRZQwXfSYpq-awlQLsbCkatlKZ6VFMRlM3MepNy3BxyYXRtcJ_dHFERFREvGe6f169X-JxXRs5fp-_o5dnw_9tMOMgh3jYcW2WgbrdYKEM04NSpG3GfFIy2wHyXuzi1xpD1Fl5QGAwXMvz0tZbTuV_hHsJ6hvmR1DSS2rUKGbv9eqcBAVT97YLNC3PoF61KUjHg5Z0BgHMQ9f0yFtUB4lfBKz8Snc9oOUDkwcZ_a3rNkL356UcwZlJPzqHBqi6c9dKdrElmhGRdpE5ixEEOl6igjvAmq7NF3uFt9AZZBG4Swcxk9XcJiLdHhGqwbl7Otb1dHJZvNrbZtfAZF7JA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MACROLIDE+SENOLYTIC+COMPOUNDS&rft.inventor=SOTGIA%2C+Federica&rft.inventor=LISANTI%2C+Michael+P&rft.inventor=OZSVARI%2C+B%C3%A9la&rft.inventor=KANGASMETSA%2C+Jussi&rft.date=2023-12-07&rft.externalDBID=A1&rft.externalDocID=WO2023233301A1